CHAKRAVARTHY V, A.; BBV, S.; A, P. K. METHOD DEVELOPMENT AND VALIDATION OF ULTRAVIOLET-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF HEPATITIS-C DRUGS - DACLATASVIR AND SOFOSBUVIR IN ACTIVE PHARMACEUTICAL INGREDIENT FORM. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 9, n. 9, p. 61–66, 2016. DOI: 10.22159/ajpcr.2016.v9s3.14616. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/14616. Acesso em: 24 nov. 2024.